Hetero’s Tocira approved for COVID treatment in hospitalised adults

Hyderabad

The authorisation will enable the medical practitioners to use the generic drug Tocilizumab for the treatment of COVID-19 in hospitalised adults who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO), the company statement said. “We are pleased with the approval of Hetero’s Tocilizumab (Tocira) in India,” said Dr B Partha Saradhi Reddy, Chairman of Hetero Group.